Responses to Cabozantinib plus Atezolizumab in a wide population of advanced and progressive neuroendocrine neoplasms (NENs): A prospective multi-cohort basket phase II Trial (CABATEN / GETNE-T1914)

被引：0

作者：

Molina-Cerrillo, J. ^{[1
]}

Grande, E. ^{[2
]}

Benavent, M. ^{[3
]}

Garcia-Carbonero, R. ^{[4
]}

Teule, A. ^{[5
]}

Custodio, A. ^{[6
]}

Jimenez-Fonseca, P. ^{[7
]}

Hierro, C. ^{[8
]}

Lopez, C. ^{[9
]}

Sevilla, I ^{[10
]}

Llanos, M. ^{[11
]}

Capdevila, J. ^{[12
]}

机构：

[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain

[2] MD Anderson Canc Ctr Madrid, Med Oncol Dept, Madrid, Spain

[3] Univ Hosp Virgen Rocio, Inst Biomed Sevilla IBIS, Med Oncol Dept, Seville, Spain

[4] UCM, Hosp Univ 12 Octubre, Med Oncol Dept, Imas12, Madrid, Spain

[5] Inst Catala Oncol ICO IDIBELL, Med Oncol Dept, Lhospitalet De Llobregat, Spain

[6] Hosp Univ La Paz, Med Oncol Dept, IdiPAZ, Madrid, Spain

[7] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain

[8] Germans Trias & Pujol Univ Hosp, Med Oncol Dept, Catalan Inst Oncol ICO Badalona, Badalona, Spain

[9] Hosp Univ Marques Valdecilla, Med Oncol Dept, IDIVAL, Santander, Spain

[10] Hosp Univ, Med Oncol Dept, Invest Clin & Traslac Canc, Inst Invest Biomed Malaga IBIMA, Malaga, Spain

[11] Hosp Univ Canarias, Med Oncol Dept, San Cristobal La Laguna, Spain

[12] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Med Oncol Dept, Barcelona, Spain

来源：

关键词：

neuroendocrine neoplasm; cabozantinib; atezolizumab; cabaten; prospective multi-cohort basket phase 2 trial;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

I21

引用

页码：245 / 245

页数：1